July 21, 2014

E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research

ALBANY, New York, July 21, 2014 /PRNewswire/ --

According to a new market report published by Transparency Market Research "E-Clinical
Solution Software Market- Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2014 - 2020," the global microfluidic device market was valued at USD 3,005
million in 2014 and is expected to grow at a CAGR of 13.8% from 2014 to 2020, to reach an
estimated value of USD 6,515.3 million in 2020.

Browse the full E-Clinical Solution Software Market Report with TOC at

Globally, the e-clinical solution software market is witnessing significant growth due
to increasing clinical trials and R&D investments in pharmaceuticals and life science.
Increasing prevalence of diseases supports clinical trials in different regions. Various
lifestyle associated diseases and genetic disorders in the Middle East and North African
countries have also enhanced clinical trials in the respective regions. In addition, the
pharmaceutical industry is facing immense pressure to reduce the time consumed during
clinical trials and to raise the productivity of drugs. Presence of various end users such
as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has
increased the acceptance of e-clinical solution software. The global e-clinical solution
software market is estimated at USD 3,005 million in 2014. It is likely to grow at a CAGR
of 13.8% from 2014 to 2020 to reach USD 6,515.3 million in 2020.

North America is a traditional clinical trial region. The average cost of
pharmaceutical research and development for a successful drug continues to increase from
pre-clinical stage i.e. initial development stage of drug till FDA approval i.e. drug is
launched in market. According to Oracle Corporation, an e-clinical software company, the
percentage share of global clinical trials conducted in North America has reduced from 30%
in 2006 to 19% in 2010. This was due to regulatory and legal considerations, which shifted
the clinical trial market from North America to developing countries such as India and
China. This may lead to sluggish growth of clinical trials in the region.

In Europe, Countries in Central and Eastern Europe provide abundant opportunities to
life science companies for clinical development. According to Oracle Corporation, the
percentage of clinical trials conducted in Western Europe has decreased from 25% to 19%
and in Eastern Europe, the percentage has increased from 10% to 13% during 2006-2010.
Similarly, according to the U.S. National Institutes of Health (Clinical Trial government
registry), the clinical trials conducted in Europe were 46,192 in May 2014.

However, Asia has become one of the fastest-growing markets for pharmaceutical
products. Improved industry regulatory laws and patent expiration laws in various
countries including Japan, China and India, have led to the expansion of the clinical
trials market in Asia. Asia has lower cost of conducting clinical trials compared to
Europe or the U.S.

Related & Recently Published Reports by Transparency Market Research

        - Drugs of Abuse Testing Market:
        - Ophthalmic Drugs Market:
        - Forensic Technologies Market:

Oracle Corporation, Medidata Solutions, PAREXEL International Corporation, BioClinica,
OmniComm Systems and others are the major players of e-clinical solution software market.

The e-clinical solution software market is segmented as follows:

E-Clinical Solution Software Market, By Mode of Delivery

        - Web based e-clinical solution software
        - Licensed Enterprise e-clinical solution software
        - Cloud based e-clinical solution software

E-Clinical Solution Software Market, By Products

        - Clinical Data Management
        - Clinical Trial Management System
        - Electronic Clinical Outcome Assessment Solution
        - Randomization and Trial Supply Management
        - Safety Solution

E-Clinical Solution Software Market, By End Users

        - Pharmaceutical
        - Clinical Research Organizations
        - Healthcare Providers

Browse the full E-Clinical Solution Software Market Report with TOC at

E-Clinical Solution Software Market, by Geography

        - North America
             - U.S.
        - Europe
             - Germany
             - France
             - U.K.
             - Italy
             - Spain
             - Poland
             - Russia
        - Asia
             - China
             - South Korea
             - Taiwan
             - India
        - Rest of the World (Row)

Browse All Pharmaceutical Market Research Reports @

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers.
TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data
sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business

        Ms. Sheela AK
        90 Sate Street, Suite 700
        Albany, NY 12207
        Tel: +1-518-618-1030
        USA - Canada Toll Free: 866-552-3453
        Email: [email protected]
        Website: http://www.transparencymarketresearch.com
        Company Blog: http://www.tmrblog.com
        Blog: http://transparencymarketresearch.areavoices.com

SOURCE www.transparencymarketresearch.com